QuantumPharm (XtalPi) Begins Trading on Hong Kong Stock Exchange
QuantumPharm, operating as XtalPi, an AI-driven drug research company from China, commenced trading on the Hong Kong Stock Exchange on …
All Posts
Cytomos Launches Benchtop Cell Analyzer
Cytomos has introduced Celledonia, a benchtop cell analyzer that promises to transform bioprocessing by delivering near real-time, cell-specific insights. Utilizing …
Lantern Pharma Receives Japanese Patent for Oncology Drug Candidate LP-284
Lantern Pharma Inc., an AI-driven company focused on oncology drug development, has announced that the Japan Patent Office (JPO) has granted …
Lokavant Introduces AI Solution for Comprehensive Clinical Trial Optimization
Lokavant has unveiled Spectrum, an AI software solution designed to enhance clinical trial feasibility and optimization throughout the entire clinical …
New LENSai API by BioStrand Integrates Large Language Models with Health Data for Advanced Drug Development
BioStrand, a subsidiary of ImmunoPrecise Antibodies Ltd. (IPA), has launched its new LENSai API software, designed to integrate large databases …
The Rise of Cyclic Peptides: Bridging the Gap in Modern Medicine
Cyclic peptides, characterized by their unique ring structures, represent an emerging trend in drug discovery due to their ability to …
Envisagenics Secures $25 Million Series B Funding to Advance RNA Splicing Therapeutics
Envisagenics, an AI-enabled biotechnology firm specializing in RNA splicing therapeutics, has announced the completion of its Series B funding round. …
FDA and CluePoints Extend Collaboration to Enhance Clinical Trial Data Integrity with AI and Machine Learning
The Food and Drug Administration (FDA) and CluePoints, a provider of statistical and AI-driven software solutions, have entered a new …
Nobel Laureate Inaugurates New Molecular Devices Facility for Manufacturing Patient-Derived Organoids
Molecular Devices, LLC, a leader in high-performance life science solutions, has officially opened its state-of-the-art facility in Cardiff, UK. This …
Merck KGaA Partners with Biolojic Design for $376M Antibody-Drug Conjugate Development
Merck KGaA has entered into a collaboration with Biolojic Design to develop new oncology and immunology therapeutics using Biolojic’s AI-driven …
Paige Introduces Multi-Modal AI for Enhanced Precision Oncology and Drug Discovery
Paige, a provider of digital pathology solutions and AI applications, has launched a new service line leveraging its Foundation Models. …
Insmed Announces Positive Results from ASPEN Study of Brensocatib in Bronchiectasis Patients
Insmed Incorporated has reported positive topline results from the ASPEN study, a pivotal Phase III clinical trial evaluating the efficacy, …